Eiman Aleem
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cell Biology top 5%
- Microtubule and mitosis dynamics
Papers in
-
- Ubiquitin and proteasome pathways 6
- Epigenetics and DNA Methylation 4
- Oncology 17
- Cancer-related Molecular Pathways 13
- Co-authors
- Philipp Kaldis (11 shared papers)Cyril Berthet (3 shared papers)Lino Tessarollo (1 shared paper)Vincenzo Coppola (1 shared paper)Hiroaki Kiyokawa (1 shared paper)R.J. Arceci (3 shared papers)Olle Larsson (4 shared papers)Scott K. Durum (2 shared papers)
- Journals
- Cell Cycle (3 papers)Cancer Research (2 papers)International Journal of Oncology (2 papers)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Molecular and Cellular Biochemistry (1 paper)
- Partner nations
- United StatesEgyptUnited Kingdom
In The Last Decade
Eiman Aleem
36 papers receiving 1.8k citations
Eiman Aleem's Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 768
- Cell Biology 416
- Molecular Biology 1.0k
- Cancer Research 175
- Pathology and Forensic Medicine 129
Countries citing papers authored by Eiman Aleem
This map shows the geographic impact of Eiman Aleem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiman Aleem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiman Aleem more than expected).
Fields of papers citing papers by Eiman Aleem
This network shows the impact of papers produced by Eiman Aleem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiman Aleem. The network helps show where Eiman Aleem may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiman Aleem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cdk2 Knockout Mice Are Viable Hit paper breakdown → | 2003 | 549 |
| 2 | 2005 | 317 | |
| 3 | 2015 | 100 | |
| 4 | 2006 | 86 | |
| 5 | 2006 | 79 | |
| 6 | 2005 | 74 | |
| 7 | 2013 | 61 | |
| 8 | 2023 | 60 | |
| 9 | 2011 | 53 | |
| 10 | 2017 | 48 | |
| 11 | 2012 | 43 | |
| 12 | 2011 | 41 | |
| 13 | 2004 | 37 | |
| 14 | 2006 | 35 | |
| 15 | 2009 | 32 | |
| 16 | 2017 | 32 | |
| 17 | 2000 | 24 | |
| 18 | 2014 | 22 | |
| 19 | 2006 | 21 | |
| 20 | 2020 | 19 |
About Eiman Aleem
Eiman Aleem is a scholar working on Molecular Biology, Oncology, Pharmacology, Cell Biology and Endocrinology, Diabetes and Metabolism, having authored 38 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (13 papers), Ubiquitin and proteasome pathways (6 papers), Microtubule and mitosis dynamics (5 papers), Epigenetics and DNA Methylation (4 papers), Fungal Biology and Applications (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Liver physiology and pathology (3 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Oncology (768 citations), Cell Biology (416 citations), Molecular Biology (1.0k citations), Cancer Research (175 citations) and Pathology and Forensic Medicine (129 citations). Eiman Aleem has collaborated with scholars based in United States, Egypt and United Kingdom. Frequent co-authors include Philipp Kaldis, Cyril Berthet, Lino Tessarollo, Vincenzo Coppola, Hiroaki Kiyokawa, R.J. Arceci, Olle Larsson, Scott K. Durum, Wenqing Li and Annette R. Khaled. Their work appears in journals such as Cell Cycle, Cancer Research, International Journal of Oncology, Anti-Cancer Agents in Medicinal Chemistry and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.